Pharmaboardroom.com: Interview with ARCHIMEDlife CEO David Kasper in Austria issue of “Healthcare and Life Sciences Review”

16. Oktober 2017

Pharmaboardroom.com interviewed ARCHIMEDlife CEO David Kasper for their latest Austria issue of „Healthcare and Life Sciences Review”. Find out...

Read more

ARCHIMEDlife @ MSACL Salzburg: Mass Spectrometry Applications to Clinical Lab, 10.- 4.9.17

13. September 2017

We are proud to be a regular part of MSACL –  this year in Salzburg from 10.- 14. September...

Read more

Become part of our readers´ community

4. September 2017

You can easily subscribe to our monthly ARCHIMEDlife Newsletter and read about laboratory diagnostics, research studies, scientific publications and...

Read more

Our new Website is online!

1. September 2017

WELCOME! We are happy to announce that our new website is online. From now on you can find all...

Read more

Newborn Screening Awareness Month: Expanded Newborn Screening for dozens of metabolic diseases

1. September 2017

September is Newborn Screening Awareness Month. Not only throughout this time we like to remind you, that you can...

Read more

Now published: A consensus guideline for newborn screening by mass spectrometry

25. Juli 2017

An updated Consensus Guideline by worldwide experts is now available: See the publication of CLSI document NBS04-Ed2, Newborn Screening...

Read more

Genotype, phenotype and disease severity reflected by serum LysoGb3 levels in patients with Fabry disease

5. Juli 2017

Background: Fabry disease (FD) is a rare X-linked lysosomal storage disease caused by mutations in the α-galactosidase A (GLA)...

Read more

Detect Severe combined immunodeficiency (SCID) early at birth!

21. Juni 2017

We offer TREC (T-cell receptor excision circle) DNA testing from Dried Blood Spots to aid in screening newborns for...

Read more

Correlation of Lyso-Gb3 levels in dried blood spots and sera from patients with classic and Later-Onset Fabry disease

16. Juni 2017

Background: Fabry disease (FD), an X-linked lysosomal storage disorder, results from the deficient activity of α-galactosidase A (α-Gal A)...

Read more